| Wed, 23 Aug 2017 14:12:13: | Amid dwindling cash and a Nasdaq warning, MabVax seeks ‘strategic options’
|
| Wed, 23 Aug 2017 12:59:05: | Phase 3 fail prompts Ultragenyx to can muscle disease drug
|
| Wed, 23 Aug 2017 12:31:25: | Paratek rising fast after Bloomberg says it is up for sale
|
| Wed, 23 Aug 2017 12:18:34: | Longevity Fund raises cash to back anti-aging startups
|
| Tue, 22 Aug 2017 13:12:28: | Lilly pens deal for Evotec spinout’s immune tolerance drugs
|
| Tue, 22 Aug 2017 12:21:18: | Microbiome startup Axial gains DepoMed executive as new CMO
|
| Tue, 22 Aug 2017 12:00:25: | Encore makes pipeline play, licensing psoriasis drug from Dr. Reddy's
|
| Tue, 22 Aug 2017 09:33:08: | Krystal files for IPO to move gene therapies into clinic
|
| Tue, 22 Aug 2017 08:56:15: | Parexel, Osaka International Cancer Institute combine for Japan trial work
|
| Mon, 21 Aug 2017 12:24:31: | Will third trial be the charm for Alkermes' depression drug?
|
| Mon, 21 Aug 2017 12:19:43: | Upstart Blade nabs Bristol-Myers Squibb research executive as new R&D lead
|
| Mon, 21 Aug 2017 12:01:10: | New CEO takes the helm at Akari as it tries to navigate choppy waters
|
| Mon, 21 Aug 2017 11:16:47: | Samsung jumps into novel drug R&D through Takeda deal
|
| Mon, 21 Aug 2017 09:00:18: | AstraZeneca inks respiratory disease mRNA pact with Ethris
|
| Fri, 18 Aug 2017 11:41:09: | Medivir sells Chinese rights to hepatitis C drug to Ascletis
|
| Fri, 18 Aug 2017 09:00:35: | Biotech deals down by half and could be lowest since 2013: report
|
| Fri, 18 Aug 2017 08:37:28: | Five Prime names ex-Genentech I-O specialist research SVP
|
| Fri, 18 Aug 2017 03:01:54: | Arcus adds WuXi Biologics-developed PD-1 drug under $816M deal
|
| Thu, 17 Aug 2017 19:34:48: | Chutes & Ladders—Novartis lures UCSF cardiovascular scientist Coughlin
|
| Thu, 17 Aug 2017 14:14:44: | EuroBiotech Report—Mullen backs Vicarius, GlaxoSmithKline jilts Ionis, CellAct lands $250M deal and data on Sanofi diabetes pill
|
| Thu, 17 Aug 2017 13:04:57: | Novartis entices UCSF director to senior position at NIBR
|
| Thu, 17 Aug 2017 13:01:58: | Big Pharma ally Atreca scoops $35M as I-O assets near IND
|
| Thu, 17 Aug 2017 12:12:40: | Leading transatlantic cancer teams form Sigma1 pact
|
| Wed, 16 Aug 2017 12:04:27: | FDA under fire over accelerated approval data demands
|
| Wed, 16 Aug 2017 11:45:33: | Takeda R&D reboot continues with Stanford drug discovery deal
|
